Key facts
- Medeloop’s last known valuation is $62.0M.
- It has raised $24.5M across 1 recorded rounds; the latest was Early Stage VC ($15.5M) in Oct 2024.
- Notable investors include General Catalyst, Inovia Capital, Icon Ventures, Maven Ventures, CFO Advisors — 11 tracked in total.
- Medeloop has filed 1 Form D with the SEC, most recently Nov 2024 ($15.5M sold to 8 investors).
- Status: Privately Held (backing).
Leadership
- Raghav SamavedamFounder
- Alex WuHead
- Anand HirekaturExecutive
- Josh WalonoskiExecutive Officer & Founder
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Medeloop
Funding rounds
1 roundsAbout Medeloop
Developer of an artificial intelligence-native platform designed to support clinical and public health research. The company offers no-code analytics, AI-supported study management, secure data access, and automated grant preparation, enabling researchers and clinicians to carry out their work with greater clarity and consistency.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 37
- Website
- medeloop.ai/
- Ownership
- Privately Held (backing)
Medeloop doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medeloop shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medeloop in its N-PORT filings yet. We sweep new filings monthly.